Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50
Closed -$3.78K 386
2026
Q1
$3.78K Hold
50
﹤0.01% 285
2025
Q4
$3.73K Hold
50
﹤0.01% 287
2025
Q3
$3.38K Hold
50
﹤0.01% 287
2025
Q2
$3.26K Hold
50
﹤0.01% 273
2025
Q1
$3.09K Hold
50
﹤0.01% 272
2024
Q4
$3.6K Buy
+50
New +$3.91K ﹤0.01% 251

Other funds holding HOLX

Graney & King's HOLX Position: Q2 2026 in Review

Graney & King sold out of Hologic (HOLX) in Q2 2026, closing a stake of 50 shares — an estimated $3.78K sold.

Graney & King first reported a position in HOLX in Q4 2024 and held it in 6 quarters. The position peaked at $3.78K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Graney & King reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Graney & King sold 50 Hologic shares in Q2 2026, an estimated $3.78K.
  • Graney & King first reported a position in Hologic in Q4 2024 and held it in 6 quarters.
  • Graney & King's Hologic position peaked at $3.78K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.